Study Stopped
due to personnel and financial restrictions, the study could not be conducted
Koebner's Phenomenon in Psoriasis and Lichen Planus
RENBOEK
A Prospective Study to Investigate the Pathophysiology of the Koebner's Phenomenon in Psoriasis and Lichen Planus
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
Psoriasis and lichen planus often occur at mechanically irritated skin sites (e.g. tight clothing). The investigators would like to investigate this phenomenon in more detail in this study. For this purpose, the skin is specifically irritated at a small and cosmetically favorable site by tearing off scotch tape or rubbing with a wooden spatula. In order to be able to examine the inflammatory processes caused by the irritation more closely, a small skin sample and a skin swab are taken from the irritated area. This skin sample and the swab are repeated after three and fourteen days.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Sep 2025
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 11, 2023
CompletedFirst Posted
Study publicly available on registry
September 1, 2023
CompletedStudy Start
First participant enrolled
September 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 20, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 20, 2025
CompletedMarch 17, 2026
March 1, 2025
19 days
August 11, 2023
March 16, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Differences in the transcriptomic profile comparing psoriasis patients with and without induced koebner phenomenon
Transcriptomic profile at all timepoints (reads per 55µm diameter dot)
Day 0, Day 3 (optional), Day 14 (optional)
Secondary Outcomes (3)
Differences in the proteomic profile comparing psoriasis patients with and without induced koebner phenomenon
Day 0, Day 3 (optional), Day 14 (optional)
Characterization of involved immune cells in the skin comparing psoriasis patients with and without induced koebner phenomenon
Day 0, Day 3 (optional), Day 14 (optional)
Characterization of skin mikrobiome
Day 0, Day 3, Day 14
Study Arms (1)
Tape stripping
EXPERIMENTALInterventions
a small area of skin will be tape-stripped with adhesive tape for up to 40 times and/or rubbed with a wooden spatula until the skin shows a slight erythema
Eligibility Criteria
You may qualify if:
- Dermatologist diagnosed psoriasis (group psoriasis), lichen planus (group lichen planus) or no skin disease (group healthy controls)
- Subject is capable of giving informed consent
- Signed informed consent
You may not qualify if:
- Use of systemic immunosuppressive/immunmodulating agents in the last three months
- Use of topical anti-inflammatory treatment in the last 7 days in the area of sampling.
- Phototherapy in the last 4 weeks
- Active or recurrent serious bacterial, fungal or viral infection at the time of enrollment by patient history, including patients with Human Immunodeficiency Virus (HIV) infection, Hepatitis B and Hepatitis C infection, active or untreated latent tuberculosis.
- Female patients of childbearing potential who are pregnant or breast feeding or planning a pregnancy during the duration of the trial and/or not practicing acceptable birth control for the duration of the trial
- Known or suspected non-compliance, drug or alcohol abuse,
- Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant,
- Previous enrolment into the current study,
- Enrolment of the investigator, his/her family members, employees and other dependent persons.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marie-Charlotte Brüggen, MD PhD
University of Zurich
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Prof. Dr. med. PhD
Study Record Dates
First Submitted
August 11, 2023
First Posted
September 1, 2023
Study Start
September 1, 2025
Primary Completion
September 20, 2025
Study Completion
September 20, 2025
Last Updated
March 17, 2026
Record last verified: 2025-03